Medline Inc. Class A Common Stock Capital Reinvestment Ratio
Medline Inc. Class A Common Stock capital reinvestment ratio. Medline Inc. Class A Common Stock (MDLN) has a Capital Reinvestment Ratio of 0.16x as of June 2026, meaning it reinvests 0% of its operating cash flow ($715.00 Million) in capital expenditures ($111.00 Million). Check Medline Inc. Class A Common Stock (MDLN) reinvestment rate to assess the company's total reinvestment commitment from operating cash flow.
Capital Reinvestment Ratio
Operating Cash Flow
Capital Expenditures
Data as of
Capital Reinvestment Ratio of Medline Inc. Class A Common Stock (2022–2025)
Capital reinvestment ratio of Medline Inc. Class A Common Stock from 2022 to 2025. This chart tracks Medline Inc. Class A Common Stock's Capital Reinvestment Ratio across 4 annual periods. Also explore net asset momentum of Medline Inc. Class A Common Stock to track the company's year-over-year net asset growth rate.
Medline Inc. Class A Common Stock Capital Reinvestment Ratio by Year (2022–2025)
Medline Inc. Class A Common Stock capital reinvestment ratio by year from 2022 to 2025. For the full cash flow conversion analysis, see MDLN cash generation efficiency.
| Year | Reinvestment Ratio | Operating CF (USD) | Capital Expenditures | YoY Change |
|---|---|---|---|---|
| 2025 | 0.26x | $1.74 Billion | $447.00 Million | ▲ +24.6% |
| 2024 | 0.21x | $1.77 Billion | $364.00 Million | ▲ +21.7% |
| 2023 | 0.17x | $1.69 Billion | $285.00 Million | ▼ -87.5% |
| 2022 | 1.36x | $187.00 Million | $254.00 Million | — |